HIMS
Price
$27.68
Change
-$1.99 (-6.71%)
Updated
Oct 30 closing price
Capitalization
6.46B
7 days until earnings call
Intraday BUY SELL Signals
IRWD
Price
$3.50
Change
-$0.12 (-3.31%)
Updated
Oct 30 closing price
Capitalization
578.34M
3 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HIMS vs IRWD

HIMS vs IRWD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HIMS vs. IRWD commentary
Nov 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIMS is a Buy and IRWD is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HIMS with price predictions
Oct 30, 2026

HIMS in +6.27% Uptrend, growing for three consecutive days on October 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HIMS advanced for three days, in 241 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 61 cases where HIMS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIMS as a result. In 65 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

The Moving Average Convergence Divergence Histogram (MACD) for HIMS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 33 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.

HIMS moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HIMS crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

HIMS broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HIMS entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. HIMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.928) is normal, around the industry mean (8.329). P/E Ratio (-44.645) is within average values for comparable stocks, (-1.568). Projected Growth (PEG Ratio) (2.624) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (2.686) is also within normal values, averaging (178.797).

The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for IRWD with price predictions
Oct 30, 2026

IRWD sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for IRWD moved below the 200-day moving average on October 27, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

IRWD moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IRWD crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRWD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for IRWD entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IRWD's RSI Indicator exited the oversold zone, 27 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 52 cases where IRWD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on IRWD as a result. In 71 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The Moving Average Convergence Divergence (MACD) for IRWD just turned positive on October 28, 2026. Looking at past instances where IRWD's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.

Following a +3.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRWD advanced for three days, in 180 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

IRWD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.573) is normal, around the industry mean (8.329). P/E Ratio (4.375) is within average values for comparable stocks, (-1.568). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. IRWD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
HIMS vs IRWD: Fundamental Ratings
HIMS
IRWD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6148
P/E GROWTH RATING
1..100
9895
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRWD's Valuation (19) in the Pharmaceuticals Other industry is somewhat better than the same rating for HIMS (66) in the null industry. This means that IRWD’s stock grew somewhat faster than HIMS’s over the last 12 months.

HIMS's Profit vs Risk Rating (74) in the null industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that HIMS’s stock grew similarly to IRWD’s over the last 12 months.

HIMS's SMR Rating (97) in the null industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that HIMS’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as HIMS (61) in the null industry. This means that IRWD’s stock grew similarly to HIMS’s over the last 12 months.

IRWD's P/E Growth Rating (95) in the Pharmaceuticals Other industry is in the same range as HIMS (98) in the null industry. This means that IRWD’s stock grew similarly to HIMS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HIMSIRWD
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 20 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
79%
COMPARISON
Comparison
Nov 02, 2026
Stock price -- (HIMS: $27.68 vs. IRWD: $3.50)
Brand notoriety: HIMS and IRWD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HIMS: 111% vs. IRWD: 83%
Market capitalization -- HIMS: $6.46B vs. IRWD: $578.34M
HIMS [@Pharmaceuticals: Generic] is valued at $6.46B. IRWD’s [@Pharmaceuticals: Generic] market capitalization is $578.34M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIMS’s FA Score shows that 0 FA rating(s) are green while IRWD’s FA Score has 1 green FA rating(s).

  • HIMS’s FA Score: 0 green, 5 red.
  • IRWD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRWD is a better buy in the long-term than HIMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIMS’s TA Score shows that 1 TA indicator(s) are bullish while IRWD’s TA Score has 6 bullish TA indicator(s).

  • HIMS’s TA Score: 1 bullish, 8 bearish.
  • IRWD’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, IRWD is a better buy in the short-term than HIMS.

Price Growth

HIMS (@Pharmaceuticals: Generic) experienced а -0.11% price change this week, while IRWD (@Pharmaceuticals: Generic) price change was +1.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.14%. For the same industry, the average monthly price growth was -9.43%, and the average quarterly price growth was +3.28%.

Reported Earning Dates

HIMS is expected to report earnings on Nov 09, 2026.

IRWD is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.14% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
HIMS
Daily Signal:
Gain/Loss:
IRWD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HIMS and

Correlation & Price change

A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-6.71%
COTY - HIMS
31%
Poorly correlated
+1.49%
HROW - HIMS
25%
Poorly correlated
-5.84%
IRWD - HIMS
25%
Poorly correlated
-3.31%
EVO - HIMS
24%
Poorly correlated
-3.16%
IPAR - HIMS
24%
Poorly correlated
+0.75%
More

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-3.31%
ACET - IRWD
30%
Poorly correlated
-4.47%
PRGO - IRWD
29%
Poorly correlated
-0.75%
TLRY - IRWD
25%
Poorly correlated
-4.17%
IXHL - IRWD
24%
Poorly correlated
-2.33%
AMRX - IRWD
24%
Poorly correlated
+0.75%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSCY19.900.04
+0.20%
Invesco BulletShares 2034 Corporate Bond ETF (BSCY)
CHGX33.05N/A
N/A
EA SERIES TRUST STANCE SUSTAINABLE BETA ETF
IALT29.47-0.48
-1.60%
iShares Systematic Alternatives Active ETF (IALT)
QBQV26.01-0.64
-2.40%
AllianzIM Growth-100 Buffer5 ETF (QBQV)
GEVG16.89-1.43
-7.79%
Leverage Shares 2X Long GEV Daily ETF (GEVG)